Primer on Prostate Cancer pp 5-15 | Cite as
Clinical Features and Diagnosis of Prostate Cancer
Abstract
The prostate is a compound tubuloalveolar exocrine gland that is part of the male reproductive system (Fig. 2.1) [1]. The normal adult prostate is around the size of a walnut and increases in size with age. It is situated at the base of the bladder and surrounds the urethra. The rectum sits posteriorly, allowing for the prostate to be palpated via rectal examination. The gland produces approximately 20 % of the fluid produced during ejaculation; the remainder is produced by the testicles and seminal vesicles. The prostate gland contains smooth muscle fibers in addition to the glandular tissues, which contracts during ejaculation.
Keywords
Prostate Cancer Prostate Gland Digital Rectal Examination American Urologic Association Benign Prostatic HypertrophyPreview
Unable to display preview. Download preview PDF.
References
- 1.Theodorescu D. Prostate cancer, clinical oncology. In: Schwab M, ed. Encyclopedic Reference of Cancer. Berlin, Germany: Springer-Verlag; 2001:720–727.Google Scholar
- 2.American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science + Business Media; 2010.Google Scholar
- 3.Taylor JA, Albertsen PC. Benign and malignant disease of the prostate. In: Rosenthal RA, Zenilman ME, Katlic MR, eds. Principles and Practice of Geriatric Surgery. 2nd ed. New York, NY: Springer Science + Business Media; 2011:1069–1082.Google Scholar
- 4.Descotes J-L, Legeais D, Gauchez A-S, Long J-A, Rambeaud J-J. PSA measurement following prostatectomy: an unexpected error. Anticancer Res. 2007;27:1149–1150.Google Scholar
- 5.Basch E, Oliver TK, Vickers A, et al. Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology provisional clinical opinion. J Clin Oncol. 2012;30:3020–3025.Google Scholar
- 6.Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. www.auanet.org/common/pdf/education/clinical-guidance/Prostate-Cancer-Detection.pdf. Accessed July 18, 2013.
- 7.Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59:61–71.Google Scholar
- 8.Gupta RT, Kauffman CR, Polascik TJ, Taneja SS, Rosenkrantz AB. The state of prostate MRI in 2013. Oncology (Williston Park). 2013;27:262–270.Google Scholar
- 9.Huang PW, Lee C-H, Lin P-L. Classifying pathological prostate images by fractal analysis. In: Chatterjee A, Siarry P, eds. Computational Intelligence in Image Processing. Heidelberg, Germany: Springer-Verlag Berlin Heidelberg; 2013:253–263.Google Scholar
- 10.Horwich A, Parker C, Bangma C, Kataja V; on behalf of the ESMO Guidelines Working Group. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 20;21(suppl 5):v129–v133.Google Scholar
- 11.National Comprehensive Cancer Center (NCCN). NCCN clinical practice guidelines in oncology (NCCN Guideline®): prostate cancer. www.nccn.org/professionals/physician_gls/pdf/prostate. pdf. Accessed July 18, 2013.
- 12.National Collaborating Centre for Cancer. Prostate cancer: diagnosis and treatment. 2008. www.nice.org.uk/nicemedia/live/11924/39687/39687.pdf. Accessed July 18, 2013.
- 13.STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: a multi-stage multi-arm randomised controlled trial. www.clinicaltrials.gov/ct2/show/study/NCT00268476. Accessed July 18, 2013.